Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Deal Details: Novo Licenses Omeros’s MASP-3 Inhibitor On Oct. 15, Novo Nordisk and Seattle-based Omeros announced a definitive asset purchase and license agreement. Under the terms, Novo gains exclusive global rights to zaltenibart (OMS906) for all indications. Omeros will receive $340
BlackRock & Nvidia’s $40 Billion AI Data Center Deal – Inside the Mega-Bet Powering the AI Boom

BlackRock & Nvidia’s $40 Billion AI Data Center Deal – Inside the Mega-Bet Powering the AI Boom

BlackRock & Nvidia Lead a $40 Billion Bet on AI Infrastructure In a blockbuster deal underscoring the value of AI infrastructure, BlackRock and Nvidia are spearheading a consortium to buy Aligned Data Centers for approximately $40 billion investing.com. The acquisition, announced Wednesday,
Go toTop